Invesco’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-23,263
| Closed | -$143K | – | 3744 |
|
|
2017
Q1 | $143K | Buy |
23,263
+2,718
| +13% | +$16.7K | ﹤0.01% | 3641 |
|
|
2016
Q4 | $120K | Sell |
20,545
-207,945
| -91% | -$1.21M | ﹤0.01% | 3602 |
|
|
2016
Q3 | $1.21M | Buy |
228,490
+209,036
| +1,075% | +$1.11M | ﹤0.01% | 2861 |
|
|
2016
Q2 | $129K | Buy |
+19,454
| New | +$129K | ﹤0.01% | 3612 |
|
|
2015
Q4 | – | Sell |
-933,215
| Closed | -$3.29M | – | 3749 |
|
|
2015
Q3 | $3.29M | Sell |
933,215
-576,589
| -38% | -$2.03M | ﹤0.01% | 2166 |
|
|
2015
Q2 | $15.1M | Buy |
1,509,804
+561,622
| +59% | +$5.6M | 0.01% | 1339 |
|
|
2015
Q1 | $12.1M | Hold |
948,182
| – | – | ﹤0.01% | 1457 |
|
|
2014
Q4 | $13.4M | Hold |
948,182
| – | – | 0.01% | 1395 |
|
|
2014
Q3 | $13M | Hold |
948,182
| – | – | 0.01% | 1393 |
|
|
2014
Q2 | $14.6M | Sell |
948,182
-706,261
| -43% | -$10.9M | 0.01% | 1374 |
|
|
2014
Q1 | $28.2M | Buy |
1,654,443
+234,496
| +17% | +$4M | 0.01% | 1058 |
|
|
2013
Q4 | $18.4M | Buy |
1,419,947
+254,535
| +22% | +$3.3M | 0.01% | 1226 |
|
|
2013
Q3 | $11.8M | Buy |
1,165,412
+290,051
| +33% | +$2.93M | 0.01% | 1390 |
|
|
2013
Q2 | $6.54M | Buy |
+875,361
| New | +$6.54M | ﹤0.01% | 1675 |
|